- Home
- NQP vs RVNC Comparison
NQP vs RVNC Comparison
Compare NQP & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NQP
- RVNC
- Stock Information
- Founded
- NQP 1990
- RVNC 1999
- Country
- NQP United States
- RVNC United States
- Employees
- NQP N/A
- RVNC N/A
- Industry
- NQP Trusts Except Educational Religious and Charitable
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- NQP Finance
- RVNC Health Care
- Exchange
- NQP Nasdaq
- RVNC Nasdaq
- Market Cap
- NQP 438.1M
- RVNC 421.7M
- IPO Year
- NQP N/A
- RVNC 2014
- Fundamental
- Price
- NQP $11.57
- RVNC $3.07
- Analyst Decision
- NQP
- RVNC Hold
- Analyst Count
- NQP 0
- RVNC 9
- Target Price
- NQP N/A
- RVNC $8.45
- AVG Volume (30 Days)
- NQP 58.4K
- RVNC 3.3M
- Earning Date
- NQP 01-01-0001
- RVNC 11-07-2024
- Dividend Yield
- NQP 3.21%
- RVNC N/A
- EPS Growth
- NQP N/A
- RVNC N/A
- EPS
- NQP N/A
- RVNC N/A
- Revenue
- NQP N/A
- RVNC $256,945,000.00
- Revenue This Year
- NQP N/A
- RVNC $11.28
- Revenue Next Year
- NQP N/A
- RVNC $27.21
- P/E Ratio
- NQP N/A
- RVNC N/A
- Revenue Growth
- NQP N/A
- RVNC 25.82
- 52 Week Low
- NQP $9.65
- RVNC $2.30
- 52 Week High
- NQP $11.89
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- NQP 29.23
- RVNC 32.72
- Support Level
- NQP $12.00
- RVNC $3.01
- Resistance Level
- NQP $12.11
- RVNC $3.11
- Average True Range (ATR)
- NQP 0.09
- RVNC 0.17
- MACD
- NQP -0.04
- RVNC -0.02
- Stochastic Oscillator
- NQP 4.31
- RVNC 5.00
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.